In a reversal that came as no surprise to many observers, on Tuesday, August 11, 2020, a unanimous panel of the U.S. Court of Appeals for the Ninth Circuit reversed the decision by the U.S. District Court for the Northern...more
8/18/2020
/ Anticompetitive Behavior ,
Antitrust Violations ,
Appeals ,
Cell Phones ,
Competition ,
Federal Trade Commission (FTC) ,
FRAND ,
FTC Act ,
IP License ,
Monopolization ,
OEM ,
Patent Royalties ,
Qualcomm ,
Remand ,
Reversal ,
Sherman Act ,
Standard Essential Patents
In a recent decision in In Re Humira (Adalimumab) Antitrust Litigation, No. 19-cv-1873, Judge Shah of the Northern District of Illinois dismissed a consolidated class action complaint filed by U.S. purchasers of AbbVie Inc.’s...more
6/22/2020
/ Anti-Competitive ,
Antitrust Injuries ,
Antitrust Litigation ,
Biopharmaceutical ,
Biosimilars ,
BPCIA ,
Class Action ,
Monopolization ,
Noerr-Pennington Doctrine ,
Patent Dance ,
Pay-For-Delay ,
Pharmaceutical Industry ,
Sherman Act ,
USPTO
Just when observers thought Qualcomm could celebrate its successful litigation with Apple another decision has come down which could have major implications for Qualcomm’s business going forward.
In much-anticipated 233-page...more
5/28/2019
/ Antitrust Litigation ,
FRAND ,
Intellectual Property Protection ,
IP License ,
Monopolization ,
Patent Litigation ,
Patents ,
Popular ,
Qualcomm ,
Sherman Act ,
Standard Essential Patents ,
Telecommunications